Annual Drug Patent Expirations for RADICAVA Radicava is a drug marketed by Mitsubishi Tanabe and is included in one NDA. It is available from one supplier. There is one patent…
The post New patent expiration for Mitsubishi Tanabe drug RADICAVA appeared…
New patent expiration for Mitsubishi Tanabe drug RADICAVA Read Post »
Annual Drug Patent Expirations for FENSOLVI+KIT Fensolvi Kit is a drug marketed by Tolmar and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Tolmar drug FENSOLVI KIT appeared first…
New patent expiration for Tolmar drug FENSOLVI KIT Read Post »
Annual Drug Patent Expirations for ELIGARD+KIT Eligard Kit is a drug marketed by Tolmar Therap and is included in four NDAs. It is available from one supplier. There are five…
The post New patent expiration for Tolmar Therap drug ELIGARD KIT appeared f…
New patent expiration for Tolmar Therap drug ELIGARD KIT Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/ticagrelor?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Ticagrelor is the generic in…
New tentative approval for Dr Reddys drug ticagrelor Read Post »
Tirofiban hydrochloride is the generic ingredient in one branded drug marketed by Medicure and is included in two NDAs. There is one patent protecting this compound. Drug patent litigation for…
The post New tentative approval for Gland Pharma drug tiro…
New tentative approval for Gland Pharma drug tirofiban hydrochloride Read Post »
This chart shows the pharmaceutical companies with the most patents in Germany. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pate…
Which pharmaceutical companies have the most drug patents in Germany? Read Post »
Tirofiban hydrochloride is the generic ingredient in one branded drug marketed by Medicure and is included in two NDAs. There is one patent protecting this compound. Drug patent litigation for…
The post New tentative approval for Gland Pharma drug tiro…
New tentative approval for Gland Pharma drug tirofiban hydrochloride Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/ticagrelor?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Ticagrelor is the generic in…
New tentative approval for Dr Reddys drug ticagrelor Read Post »
This chart shows the pharmaceutical companies with the most patents in Cyprus. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…
Which pharmaceutical companies have the most drug patents in Cyprus? Read Post »
Annual Drug Patent Expirations for TIBSOVO Tibsovo is a drug marketed by Agios Pharms Inc and is included in one NDA. There are five patents protecting this drug. This drug…
The post New patent for Agios Pharms drug TIBSOVO appeared first on DrugPatent…
Get new actionable insights and updates from BiotechBlog
